Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines

Inflammation Research

Volumn 54, Issue 9, 2005, Pages 367-369

  Gillard, M ^a   Strolin Benedetti, M ^a   Chatelain, P ^a   Baltes, E ^a  

^a UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

DESLORATADINE; FEXOFENADINE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; LEVOCETIRIZINE; CETIRIZINE; DRUG DERIVATIVE; LORATADINE; PIPERAZINE DERIVATIVE; TERFENADINE;

ARTICLE; DISEASE EXACERBATION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENCY; DRUG RECEPTOR BINDING; PREDICTION; RECEPTOR AFFINITY; RECEPTOR OCCUPANCY; URTICARIA; ANIMAL; CHO CELL; CRICETULUS; GENETIC RECOMBINATION; GENETICS; HAMSTER; HUMAN; METABOLISM; PREDICTION AND FORECASTING;

ANIMALS; CETIRIZINE; CHO CELLS; CRICETINAE; CRICETULUS; HISTAMINE H1 ANTAGONISTS; HUMANS; LORATADINE; PIPERAZINES; PREDICTIVE VALUE OF TESTS; RECEPTORS, HISTAMINE H1; RECOMBINATION, GENETIC; TERFENADINE; URTICARIA;

EID: 30444441379     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-005-1368-3     Document Type: Article

References (23)

1. 194. Mol Pharmacol 2002; 61: 391-9.
2. 1 antagonists: receptor affinity versus selectivity. Inflamm res 2003; Suppl. 1: S49-50.
3. Molimard M, Diquet B, Strolin Benedetti M. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans. Fund Clin Pharmacol 2004; 18: 399-411.
4. Purohit A, Duvernelle C, Melac M, Pauli G, Frossard N. Twenty-four hours of activity of cetirizine and fexofenadine in the skin. Ann Allergy Asthma Immunol 2001; 86: 387-92.
5. Purohit A, Melac M, Pauli G, Frossard N. Twenty-four hours of activity of levocetirizine and desloratadine in the skin. Br J Clin Pharmacol 2003; 56: 388-94.
6. 11C-doxepin positron emission tomography. J Clin Pharmacol 2004; 44: 890-900.
7. Weiland GA, Molinoff PB. Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties. Life Sci 1981, 29: 313-30.
8. Molinoff PB, Wolfe BB, Weiland GA. Quantitative analysis of drug-receptor interactions: II. Determination of the properties of receptor subtypes. Life Sci 1981, 29: 427-43.
9. 1-receptor antagonists. Allergy Clin Immunol 2001; 107(3): 526-30.
10. 1-antihistamines in the skin. J Allergy Clin Immunol 2002; 110: 777-83.
11. 1-receptor antagonists in skin and serum. J. Allergy Clin Immunol 1995; 95(3): 759-64.
12. Affrime M, Baufield C, Gupta S, Cohen A, Boutrous T, Thonoor M et al. Effect of race and sex on single and multiple dose pharmacokinetics of desloratadine. Clin Pharmacokin 2002; 41(1): 21-8.
13. Wang Z, Hamman MA, Huang SM, Lesko LJ, Hall SD. Effect of St John's wort on the pharmacokinetics of fexofenadine. Clin Pharmacol Ther 2002; 71:414-20.
14. Dresser GK, Bailey DG, Leake BF, Schwarz UI, Dawson PA, Freeman DJ et al. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther 2002; 71: 11-20.
15. Baltes E, Coupez R, Giezek H, Voss G, Meyerhoff C, Strolin Benedetti M. Absorption and disposition of levocetirizine, the eutomer of cetirizine, administered alone or as cetirizine to healthy volunteers. Fund Clin Pharmacol 2001; 15: 269-77.
16. Grant JA, Riethuisen JM, Moulaert B, DeVos C. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. Ann Allergy Asthma Immunol 2002; 88:190-197.
17. Popov T, Dimitrov V, Bachvarova A, Church MK, Bocsan C, Dumitrascu D. A comparison of levocetirizine and desloratadine at equiactive doses in the histamine-induced wheal and flare response in the skin in vivo. Allergy Clin Immunol Int 2005; J. World Org, Suppl. 1: 241.
18. Denham KJ, Boutsiouki P, Clough GF, Church MK. Comparison of the effects of desloratadine and levocetirizine on histamine-induced wheal, flare and itch in human skin. Inflamm Res 2003; 52: 424-427.
19. 1 receptor. Eur J Pharmacol 2002; 449: 229-37.
20. 1-receptor binding sites in guinea pig brain membranes: regulation of agonist interactions by guanine nucleotides and cations. J Neurochem 1980; 34(4): 916-22.
21. Wang DY, Hanotte F., De Vos C, Clement P. Effect of cetirizine, levocetirizine, and dextrocetirizine on histamine induced nasal response in healthy adult volunteers. Allergy 2001; 56: 339-43.
22. Larbig M, Stamm H, Hohlfeld J, Krug N. Levocetirizine but not desloratadine inhibits histamine-induced changes of a nasal temperature measured by facial thermography: a pilot study. XXII Congress of the EAACI, Paris, June 2003; abstract book p.283, poster No. 982.
23. Larbig M, Stamm H, Casper A, Hohlfeld J, Krug N. Twenty-four hour anti-H1 activity of levocetirizine measured by thermography is superior to fexofenadine. XXIII Congress of the EAACI, Amsterdam. June 2004; abstract book p.80, poster No.248).